Heart Transplant in Patient with HIT, Anti-E and Anti-S Antibodies and Cold Agglutinins (ASA 2026) - Jul 23, 2026 - Abstract #M1042; Pres time: Oct 17, 2026; 11:05 AM - 11:15 AM; Location: Exhibit Hall; "Warfarin was reversed with a heparin-sparing regimen of vitamin K and factor IX complex. CPB anticoagulation was maintained by protocolized cangrelor and heparin. The surgery proceeded uneventfully, with no major perioperative complications."
Clinical • Cardiovascular • Congestive Heart Failure • Heart Failure • Transplantation
|
|
Eri Seng, MD1; Jonathan Ellis, MD2.
|